Cryoablation System News Today

Boston Scientific Corporation (NYSE:BSX) Q3 2023 Earnings Call Transcript October 26, 2023 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.5, expectations were $0.48. Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be […]

Operator: Good day, and welcome to the Boston Scientific Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.

Today, Boston Scientific shared its financial results for the third quarter of 2023. Overall, we generated net sales of $3.527 billion during the third quarter of 2023, growing...

MARLBOROUGH, Mass., Oct. 26, 2023 /PRNewswire/ -- Boston Scientific Corporation generated net sales of $3.527 billion during the third quarter of 2023, growing 11.2 percent on a reported basis,...

Strong performance across all sectors and regions contribute to the company's financial growth

/PRNewswire/ -- A new cryoablation procedure designed to improve treatment of paroxysmal atrial fibrillation (AFib) is being offered by St. Josephs Hospital...

Cryoablation System Gets Approved in Brazil

Banner – University Medical Center Phoenix is the first hospital in the U.S. to use an innovative technology to treat atrial fibrillation.

MedTech industry news

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff